Discover 2,122 paid clinical trials in Allentown, Pennsylvania. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,122
Active & Responsive
Pediatric Post-Approval Registry
for
Obstructive Sleep Apnea
Location: Philadelphia PA, Sewickley PA, Norfolk VA, Durham NC,
Sponsor: Inspire Medical Systems, Inc.
Sex: All
Age: 18 - 21
Code: NCT04457154
Recruiting
Active & Responsive
A Prospective Analysis of Long-Term Clinical Outcomes and 3D Spine Growth in Anterior Vertebral Body Tethering
for
Scoliosis Idiopathic
Location: Philadelphia PA, New York NY, Washington D.C. DC,
Sponsor: Pediatric Spine Foundation
Sex: All
Age: 0 - 18
Code: NCT04914507
Recruiting
Active & Responsive
A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)
for
PIK3CA-Related Overgrowth Spectrum (PROS),
Location: Philadelphia PA, New York NY, Baltimore MD, Boston MA,
Sponsor: Relay Therapeutics, Inc.
Sex: All
Age: 2+
Code: NCT06789913
Phase 2, Recruiting
Active & ResponsiveNew
A Study of COVID-19 Vaccine(s) in Children and Adults
for
COVID-19 Vaccines
Location: Philadelphia PA, South Euclid OH, Dayton OH,
Sponsor: BioNTech SE
Sex: All
Age: 5+
Code: NCT07798648
Phase 3, Recruiting
Active & Responsive
To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Philadelphia PA, Burke VA, DuBois PA, Virginia Beach VA,
Sponsor: Expedition Therapeutics, Inc
Sex: All
Age: 40 - 70+
Code: NCT07684820
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
for
Healthy Participants, Atopic Dermatitis
Location: Philadelphia PA, Troy MI, Miami FL, San Diego CA,
Sponsor: Pfizer
Sex: All
Age: 18 - 70
Code: NCT06564389
Phase 1, Recruiting
Active & Responsive
A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)